AI-generated summary
The authors systematically reviewed clinical studies of photobiomodulation for preventing or managing side effects of cancer treatments. They report that red or infrared light was effective in randomized trials for certain radiotherapy complications, notably acute mucositis, radiation dermatitis and upper limb lymphedema, with evidence rated moderate overall. Evidence for other side effects was limited.
- Who or what was studied
- Patients receiving cancer treatments such as radiation therapy, chemotherapy, and hematopoietic stem cell transplantation
- Limits stated in the abstract
- The authors note heterogeneous evidence, diverse and imprecise treatment protocols, and a lack of or limited studies for several other side effects, with long-term safety not yet established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.